HEADER PHOTOSYNTHESIS 14-MAY-10 2KY4 TITLE SOLUTION NMR STRUCTURE OF THE PBS LINKER DOMAIN OF PHYCOBILISOME TITLE 2 LINKER POLYPEPTIDE FROM ANABAENA SP. NORTHEAST STRUCTURAL GENOMICS TITLE 3 CONSORTIUM TARGET NSR123E COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHYCOBILISOME LINKER POLYPEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PBS-LINKER 3 DOMAIN RESIDUES 727-867; COMPND 5 SYNONYM: ANCHOR POLYPEPTIDE, PBS-ANCHOR PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOSTOC SP.; SOURCE 3 ORGANISM_TAXID: 103690; SOURCE 4 STRAIN: PCC 7120; SOURCE 5 GENE: ALR0020, APCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+ MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET 21-23C KEYWDS NESG, PSI, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, KEYWDS 2 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, PHOTOSYNTHESIS EXPDTA SOLUTION NMR NUMMDL 14 AUTHOR Y.HE,A.ELETSKY,J.L.MILLS,D.LEE,C.CICCOSANTI,K.HAMILTON,T.B.ACTON, AUTHOR 2 R.XIAO,J.K.EVERETT,H.LEE,J.H.PRESTEGARD,G.T.MONTELIONE,T.SZYPERSKI, AUTHOR 3 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 2 16-MAR-22 2KY4 1 REMARK SEQADV REVDAT 1 14-JUL-10 2KY4 0 JRNL AUTH Y.HE,A.ELETSKY,J.L.MILLS,D.LEE,C.CICCOSANTI,K.HAMILTON, JRNL AUTH 2 T.B.ACTON,R.XIAO,J.K.EVERETT,H.LEE,G.T.MONTELIONE, JRNL AUTH 3 T.SZYPERSKI JRNL TITL SOLUTION NMR STRUCTURE OF THE PBS LINKER DOMAIN OF JRNL TITL 2 PHYCOBILISOME LINKER POLYPEPTIDE FROM ANABAENA SP. NORTHEAST JRNL TITL 3 STRUCTURAL GENOMICS CONSORTIUM TARGET NSR123E JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMRJ 2.1B, CNS 1.2.1, MOLMOL REMARK 3 AUTHORS : VARIAN (VNMRJ), BRUNGER, ADAMS, CLORE, GROS, REMARK 3 NILGES AND READ (CNS), KORADI, BILLETER AND REMARK 3 WUTHRICH (MOLMOL) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION WAS PERFORMED REMARK 3 ITERATIVELY WITH CYANA V3.0 USING NOE-BASED CONSTRAINTS, PHI AND REMARK 3 PSI DIHEDRAL ANGLE CONSTRAINTS FROM TALOS+, AND RDC CONSTRAINTS. REMARK 3 THE 20 CONFORMERS OUT OF 100 WITH THE LOWEST TARGET FUNCTION REMARK 3 WERE FURTHER REFINED BY SIMULATED ANNEALING IN EXPLICIT WATER REMARK 3 BATH USING THE PROGRAM CNS WITH PARAM19 FORCE FIELD. REMARK 4 REMARK 4 2KY4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1000101718. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 117.5 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.95 MM [U-100% 13C; U-100% 15N] REMARK 210 PROTEIN, 100 MM SODIUM CHLORIDE, REMARK 210 5 MM CALCIUM CHLORIDE, 10 MM DTT, REMARK 210 20 MM MES, 0.02 % BY VOLUME REMARK 210 NAN3, 50 UM DSS, 90% H2O/10% D2O; REMARK 210 0.975 MM [U-5% 13C; U-100% 15N] REMARK 210 PROTEIN, 100 MM SODIUM CHLORIDE, REMARK 210 5 MM CALCIUM CHLORIDE, 10 MM DTT, REMARK 210 20 MM MES, 0.02 % BY VOLUME REMARK 210 NAN3, 50 UM DSS, 90% H2O/10% D2O; REMARK 210 0.664 MM [U-5% 13C; U-100% 15N] REMARK 210 PROTEIN, 100 MM SODIUM CHLORIDE, REMARK 210 5 MM CALCIUM CHLORIDE, 10 MM DTT, REMARK 210 20 MM MES, 0.02 % BY VOLUME REMARK 210 NAN3, 50 UM DSS, 4 % BY VOLUME REMARK 210 POLY ETHYLENE GLYCOL, 82% H2O/18% REMARK 210 D2O; 0.851 MM [U-5% 13C; U-100% REMARK 210 15N] PROTEIN, 100 MM SODIUM REMARK 210 CHLORIDE, 5 MM CALCIUM CHLORIDE, REMARK 210 10 MM DTT, 20 MM MES, 0.02 % BY REMARK 210 VOLUME NAN3, 50 UM DSS, 7 % BY REMARK 210 VOLUME POLY ACRYLAMIDE GEL, 83% REMARK 210 H2O/17% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C CT REMARK 210 -HSQC ALI; 2D 1H-13C CT-HSQC ARO; REMARK 210 2D 1H-13C CT-HSQC (METHYL); 3D REMARK 210 HNCO; 3D HN(CA)CO; 3D CBCA(CO)NH; REMARK 210 3D HNCACB; 3D HCCH-TOCSY; 3D REMARK 210 HCCH-COSY ALI; 3D HCCH-COSY ARO; REMARK 210 3D HBHA(CO)NH; 13C/15N-NOESY; 2D REMARK 210 J-MODULATION 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 600 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2007.030.16.06, PROSA REMARK 210 6.4, XEASY, AUTOASSIGN, CYANA REMARK 210 3.0, AUTOSTRUCTURE 2.2.1, TALOS+ REMARK 210 1.2009.0721.18, CARA 1.8.4, PSVS REMARK 210 1.3, NMRDRAW 3.0, TOPSPIN 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 14 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 8 82.44 -67.11 REMARK 500 1 GLU A 29 -50.67 70.68 REMARK 500 1 TYR A 73 -58.21 -154.48 REMARK 500 1 PHE A 89 -63.62 -100.54 REMARK 500 1 VAL A 128 -64.10 -100.56 REMARK 500 1 GLU A 131 21.89 -79.21 REMARK 500 1 ASP A 132 -36.62 -134.18 REMARK 500 1 PRO A 135 84.66 -66.72 REMARK 500 1 ARG A 138 40.69 -84.04 REMARK 500 1 PHE A 139 160.09 66.07 REMARK 500 1 THR A 141 -81.62 -65.14 REMARK 500 1 LEU A 142 -32.93 69.33 REMARK 500 1 HIS A 145 -25.13 74.85 REMARK 500 1 HIS A 146 96.51 -64.60 REMARK 500 2 ASP A 12 114.70 -32.75 REMARK 500 2 PHE A 41 45.76 -99.70 REMARK 500 2 TYR A 73 -42.92 -159.29 REMARK 500 2 PHE A 129 -78.49 -118.90 REMARK 500 2 PRO A 135 90.01 -48.30 REMARK 500 2 PHE A 139 146.15 73.12 REMARK 500 2 HIS A 144 90.83 -61.19 REMARK 500 2 HIS A 148 -59.85 70.46 REMARK 500 3 ALA A 8 100.55 -51.95 REMARK 500 3 PHE A 41 55.70 -116.65 REMARK 500 3 PHE A 89 -64.74 -91.05 REMARK 500 3 PRO A 135 85.62 -46.97 REMARK 500 3 ARG A 137 104.72 -56.65 REMARK 500 3 ARG A 138 83.43 -69.49 REMARK 500 3 HIS A 146 -73.54 63.63 REMARK 500 4 LYS A 11 6.64 -67.48 REMARK 500 4 GLU A 29 35.72 35.28 REMARK 500 4 PHE A 72 60.16 -111.77 REMARK 500 4 TYR A 73 -58.70 -165.57 REMARK 500 4 PHE A 89 -67.04 -98.96 REMARK 500 4 THR A 109 -71.91 -77.05 REMARK 500 4 GLU A 131 -58.13 -126.13 REMARK 500 4 GLU A 143 88.29 -69.14 REMARK 500 5 ALA A 8 94.35 -66.06 REMARK 500 5 ASP A 12 96.76 -42.68 REMARK 500 5 GLN A 26 -61.66 -95.23 REMARK 500 5 PHE A 41 52.71 -116.64 REMARK 500 5 TYR A 73 -53.07 -155.90 REMARK 500 5 PHE A 89 -65.02 -104.76 REMARK 500 5 PHE A 129 70.19 -102.76 REMARK 500 5 LEU A 142 42.74 -105.23 REMARK 500 5 HIS A 147 19.36 -167.80 REMARK 500 5 HIS A 148 88.13 -65.73 REMARK 500 6 LYS A 11 17.21 46.37 REMARK 500 6 GLU A 29 -54.48 65.97 REMARK 500 6 PHE A 41 60.27 -113.92 REMARK 500 REMARK 500 THIS ENTRY HAS 147 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 6 ARG A 138 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: NSR123E RELATED DB: TARGETDB DBREF 2KY4 A 2 142 UNP P80559 APCE_ANASP 727 867 SEQADV 2KY4 MET A 1 UNP P80559 INITIATING METHIONINE SEQADV 2KY4 GLU A 143 UNP P80559 EXPRESSION TAG SEQADV 2KY4 HIS A 144 UNP P80559 EXPRESSION TAG SEQADV 2KY4 HIS A 145 UNP P80559 EXPRESSION TAG SEQADV 2KY4 HIS A 146 UNP P80559 EXPRESSION TAG SEQADV 2KY4 HIS A 147 UNP P80559 EXPRESSION TAG SEQADV 2KY4 HIS A 148 UNP P80559 EXPRESSION TAG SEQADV 2KY4 HIS A 149 UNP P80559 EXPRESSION TAG SEQRES 1 A 149 MET LYS VAL PHE LYS ARG VAL ALA GLY ILE LYS ASP LYS SEQRES 2 A 149 ALA ALA ILE LYS THR LEU ILE SER ALA ALA TYR ARG GLN SEQRES 3 A 149 ILE PHE GLU ARG ASP ILE ALA PRO TYR ILE ALA GLN ASN SEQRES 4 A 149 GLU PHE SER GLY TRP GLU SER LYS LEU GLY ASN GLY GLU SEQRES 5 A 149 ILE THR VAL LYS GLU PHE ILE GLU GLY LEU GLY TYR SER SEQRES 6 A 149 ASN LEU TYR LEU LYS GLU PHE TYR THR PRO TYR PRO ASN SEQRES 7 A 149 THR LYS VAL ILE GLU LEU GLY THR LYS HIS PHE LEU GLY SEQRES 8 A 149 ARG ALA PRO ILE ASP GLN ALA GLU ILE ARG LYS TYR ASN SEQRES 9 A 149 GLN ILE LEU ALA THR GLN GLY ILE ARG ALA PHE ILE ASN SEQRES 10 A 149 ALA LEU VAL ASN SER GLN GLU TYR ASN GLU VAL PHE GLY SEQRES 11 A 149 GLU ASP THR VAL PRO TYR ARG ARG PHE PRO THR LEU GLU SEQRES 12 A 149 HIS HIS HIS HIS HIS HIS HELIX 1 1 ASP A 12 PHE A 28 1 17 HELIX 2 2 ALA A 33 PHE A 41 1 9 HELIX 3 3 PHE A 41 ASN A 50 1 10 HELIX 4 4 THR A 54 SER A 65 1 12 HELIX 5 5 SER A 65 TYR A 73 1 9 HELIX 6 6 PRO A 77 LEU A 90 1 14 HELIX 7 7 ASP A 96 GLN A 110 1 15 HELIX 8 8 GLY A 111 ASN A 121 1 11 HELIX 9 9 SER A 122 PHE A 129 1 8 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1